BeOne Medicines Reaches US Accord on Drug Access, Domestic Manufacturing

MT newswire2026/08/31 19:56

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

03:56 PM EDT, 08/31/2026 (MT Newswires) -- BeOne Medicines (ONC) voluntarily agreed with the US government to expand patient access to its cancer medicines and increase US manufacturing operations, the company said Monday. The company said it will join a federal pricing framework that requires future products approved by the Food and Drug Administration to be priced in line with other developed markets. Switzerland-based BeOne also reached an agreement with the US that rewards its decision to manufacture more of its medicines domestically by exempting it from certain national-security-based import tariffs. Price: 359.90, Change: -6.83, Percent Change: -1.86

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

The U.S. Energy Information Administration (EIA) has raised its forecast for average Brent crude oil prices in 2026 and 2027 to $97 and $86, respectively, reflecting pressures from global inventory declines, Middle East supply disruptions, and rising transportation costs. As oil production in the Middle East gradually recovers and global inventories rebound from low levels, the EIA expects the average spot price of Brent crude to fall to $87 per barrel in the second quarter of 2027, and further decline to $77 per barrel by the fourth quarter.

华尔街见闻•2026/11/10 18:41